2023-11-08 09:51:00
The Ministry of Health and Population confirmed that the protocols for treating multiple sclerosis have been updated, including a set of new medications and the inclusion and coding of a new wave drug and a new biosimilar. The doses have also been modified and additional doses have been introduced for patients with secondary progressive multiple sclerosis and patients with myelitis and neuritis optica (NMO), in addition to… Listing of a new drug for relapsing-remitting multiple sclerosis, and listing of another drug for central nervous system multiple sclerosis.
Dr. Hossam Abdel Ghaffar, spokesman for the Ministry of Health and Population, pointed out the modernization of protocols for rheumatic and immunological diseases and the introduction of various biological medications, within a system at state expense, to treat (immune stiffness, articular psoriasis, non-microbial immune iritis, psoriasis, and immune inflammation of the sweat glands).
Dr. Hossam Abdel Ghaffar, spokesman for the Ministry of Health and Population, noted the re-evaluation of the drug used in the treatment of hereditary immunodeficiency, to include the full number of doses according to the patient’s weight, the inclusion of a new drug in the biological treatment protocol for patients with Crohn’s disease and autoimmune ulcerative inflammation, and the activation of the second line of treatment for patients. Articular psoriasis.
1699443933
#Ministry #Health #reveals #details #updating #treatment #protocols #chronic #diseases
